A critical downstream effect could be platelet activation by collagen type I. Furthermore, increased TIMP‐1 and TIMP‐4, two nonspecific MMP inhibitors, were observed in the COVID‐19 samples. The gene discussed is TIMP1; the disease is COVID-19.